title: Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
abstract: Changes in the expression and activity of lipid-metabolizing enzymes, including the linoleic acid (LA)-metabolizing enzyme 15-lipoxygenase-1 (15-LO-1), may play a role in the development and progression of human prostate carcinoma (PCa). We reported that human 15-LO-1 (designated as leukocyte type 12-LO or 12/15-LO in mouse) is expressed in human prostate and increased in PCa, particularly high-grade PCa. Genetically engineered mouse (GEM) models of PCa could facilitate the study of this gene and its regulation and function in PCa progression. In this study, we examine the protein expression and enzyme activity levels of 12/15-LO associated with PCa progression in the TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) model of PCa. This GEM model develops prostatic intraepithelial neoplasia (PIN), followed by invasive gland-forming PCa and invasive and metastatic less differentiated PCa, with neuroendocrine (NE) differentiation (NE Ca). In the wild-type and TRAMP prostates, the most prominent LA metabolite was 13-hydroxyoctadecadienoic acid (13-HODE). Lesser amounts of 12-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid (HETE) were made from arachidonic acid (AA). In TRAMP prostates, 12/15-LO activity was increased compared to wild type at 20, 29, 39, and 49 weeks, as assessed by LA conversion to 13-HODE, and by AA conversion to 12/15-HETE, respectively. Immunostaining demonstrated that the increased capacity to generate 13-HODE was paralleled by an increase in neoplastic epithelial expression of 12/15-LO in PIN and invasive carcinomas. In conclusion, although there is a basal 12/15-LO activity in the wild-type mouse prostate, there is a marked increase in the expression of 12/15-LO with TRAMP PCa progression, paralleling our previously reported increased expression of the ortholog 15-LO-1 in high-grade human PCa. Thus, 12/15-LO and LA metabolism in the TRAMP model shares similarities to human PCa, and may allow to confirm a role for LA metabolism and other biologic functions of 15-LO-1 in human PCa. In addition, the TRAMP model will serve as a tool for testing the suitability of 12/15-LO-and ultimately human 15-LO--as a therapeutic target during PCa progression.
authors.affiliation: Department of Urology, University of Pittsburgh and Cancer Institute (UPCI), Pittsburgh, PA 15232, USA. kelavkarup@msx.upmc.edu
authors.forename: Uddhav P
authors.initials: UP
authors.lastname: Kelavkar
authors.forename: Wayne
authors.initials: W
authors.lastname: Glasgow
authors.forename: Sandra J
authors.initials: SJ
authors.lastname: Olson
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Foster
authors.forename: Scott B
authors.initials: SB
authors.lastname: Shappell
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology* / Q000473:pathology; D000818:Animals; D001092:Arachidonate 12-Lipoxygenase / Q000235:genetics / Q000378:metabolism*; D001093:Arachidonate 15-Lipoxygenase / Q000235:genetics / Q000378:metabolism*; D016718:Arachidonic Acid / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004195:Disease Models, Animal; D004789:Enzyme Activation / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D019787:Linoleic Acid / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D011471:Prostatic Neoplasms / Q000201:enzymology* / Q000473:pathology; D015854:Up-Regulation
chemical_list: C475064:12-15-lipoxygenase; D016718:Arachidonic Acid; D019787:Linoleic Acid; D001092:Arachidonate 12-Lipoxygenase; D001093:Arachidonate 15-Lipoxygenase
references.citation: Cancer Res. 1999 May 1;59(9):2203-9
references.pmid: 10232609
references.citation: Cancer Res. 2001 Jan 15;61(2):497-503
references.pmid: 11212240
references.citation: Neoplasia. 2004 Jan-Feb;6(1):41-52
references.pmid: 15068670
references.citation: Urology. 1995 Aug;46(2):227-37
references.pmid: 7624992
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4378-83
references.pmid: 10200270
references.citation: Cancer Res. 1975 Nov;35(11 Pt. 2):3240-5
references.pmid: 1192400
references.citation: Carcinogenesis. 2000 Oct;21(10):1777-87
references.pmid: 11023533
references.citation: Lab Invest. 1998 Mar;78(3):319-33
references.pmid: 9520945
references.citation: Clin Exp Metastasis. 1993 May;11(3):243-50
references.pmid: 7682484
references.citation: Cancer Res. 2004 Mar 15;64(6):2270-305
references.pmid: 15026373
references.citation: Cancer Res. 2001 Sep 15;61(18):6777-82
references.pmid: 11559550
references.citation: J Urol. 2004 Jan;171(1):439-42
references.pmid: 14665950
references.citation: Am J Pathol. 1999 Jul;155(1):235-45
references.pmid: 10393855
references.citation: Biochem Biophys Res Commun. 1997 Feb 3;231(1):111-6
references.pmid: 9070230
references.citation: Hum Pathol. 2000 Sep;31(9):1146-54
references.pmid: 11014584
references.citation: Anticancer Res. 1998 May-Jun;18(3A):1429-34
references.pmid: 9673351
references.citation: J Biol Chem. 1997 Sep 26;272(39):24410-6
references.pmid: 9305900
references.citation: Cancer Res. 2003 May 1;63(9):2256-67
references.pmid: 12727848
references.citation: Prostaglandins Leukot Essent Fatty Acids. 1998 May;58(5):339-46
references.pmid: 9690711
references.citation: J Biol Chem. 2001 Sep 14;276(37):34545-52
references.pmid: 11447213
references.citation: Cancer Lett. 2003 Mar 10;191(2):125-35
references.pmid: 12618325
references.citation: J Biol Chem. 1998 Aug 21;273(34):21569-77
references.pmid: 9705287
references.citation: Biochem Biophys Res Commun. 1997 Oct 29;239(3):775-81
references.pmid: 9367845
references.citation: J Biol Chem. 1994 May 13;269(19):13979-87
references.pmid: 8188678
references.citation: J Urol. 2004 Feb;171(2 Pt 2):S19-24
references.pmid: 14713748
references.citation: Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43
references.pmid: 7724580
references.citation: Front Biosci. 1998 Jun 8;3:E81-8
references.pmid: 9616130
references.citation: Prostate Cancer Prostatic Dis. 1999 Mar;2(2):70-75
references.pmid: 12496841
references.citation: FEBS Lett. 1993 Sep 13;330(2):156-60
references.pmid: 8365485
references.citation: Carcinogenesis. 1999 Oct;20(10):1985-95
references.pmid: 10506115
references.citation: Neoplasia. 2001 Jul-Aug;3(4):287-303
references.pmid: 11571629
references.citation: J Biol Chem. 1999 Aug 20;274(34):23679-82
references.pmid: 10446122
references.citation: J Biol Chem. 1996 Dec 27;271(52):33157-60
references.pmid: 8969167
references.citation: Trends Genet. 2002 May;18(5):S1-5
references.pmid: 12047956
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10350-5
references.pmid: 11504910
references.citation: Biochem Biophys Res Commun. 1997 Jun 18;235(2):418-23
references.pmid: 9199209
references.citation: J Natl Cancer Inst. 1968 Jan;40(1):43-68
references.pmid: 5635018
references.citation: J Biol Chem. 2002 Oct 25;277(43):40549-56
references.pmid: 12189136
references.citation: J Biol Chem. 2002 May 3;277(18):16189-201
references.pmid: 11839751
references.citation: Carcinogenesis. 2001 Nov;22(11):1765-73
references.pmid: 11698337
references.citation: Endocr Rev. 1999 Feb;20(1):22-45
references.pmid: 10047972
references.citation: Am J Clin Nutr. 1998 Jul;68(1):142-53
references.pmid: 9665108
references.citation: Cancer Res. 1999 Jan 15;59(2):360-6
references.pmid: 9927047
references.citation: Cancer Res. 2000 Apr 15;60(8):2203-8
references.pmid: 10786685